The impact of misdiagnosed heart failure and cardiac or extra-cardiac disease burden on the prognosis in patients with type 2 diabetes

BMC Cardiovascular Disorders, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1186/s12872-026-05844-3
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

BACKGROUND: We examined how misdiagnosed heart failure (HF) and the burden of cardiac and extra-cardiac diseases prognostically impact 1-year outcomes (all-cause mortality, rehospitalization, and their composite) in patients with type 2 diabetes mellitus (T2DM). METHODS: A retrospective analysis of a prospective observational cohort study was performed. This study included 1008 patients with T2DM. Misdiagnosis of HF was defined as the difference between the diagnosis of HF contained in the primary care medical records of the patient upon admission and the final diagnosis established in the hospital at discharge. We used the MAGGIC risk score. Univariate and multivariate Cox proportional hazard models were used. RESULTS: In the subgroup with misdiagnosed HF, multivariate Cox regression analysis showed that the MAGGIC noncardiac burden was the most significant predictor of the composite outcome (adjusted HR: 1.217 [1.079-1.461]; p < 0.001, and adjusted HR: 1.305 [1.119-1.561]; p < 0.001) during the 1-year follow-up. CONCLUSIONS: This longitudinal study highlights that the misdiagnosis of heart failure, both under- and overdiagnosis, is common in T2DM patients and is associated with worse long-term outcomes, even after receiving appropriate hospital-based management.